IFRX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

InflaRx N.V.

NASDAQ | IFRX

1.26

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$80.62M

Market Cap

-

P/E Ratio

-0.7

EPS

$2.81

52 Week High

$0.71

52 Week Low

HEALTHCARE

Sector

IFRX Chart

Recent Chart
Price Action

IFRX Technicals

Tags:

IFRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit -$3.2M
Total Revenue $166K
Cost Of Revenue $3.3M
Costof Goods And Services Sold $3.3M
Operating Income -$53M
Selling General And Administrative $15M
Research And Development $35M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $3.3M
Interest Income $3.2M
Interest Expense $21K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $485K
Income Before Tax -$46M
Income Tax Expense $5.2K
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$46M
Net Income -$46M

Revenue & Profitability

Earnings Performance

IFRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (EUR)
Total Assets $76M
Total Current Assets $72M
Cash And Cash Equivalents At Carrying Value $18M
Cash And Short Term Investments $18M
Inventory $6.9M
Current Net Receivables $1.7M
Total Non Current Assets $4.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $7.3K
Intangible Assets Excluding Goodwill $7.3K
Goodwill -
Investments -
Long Term Investments $3.1M
Short Term Investments $34M
Other Current Assets $46M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $14M
Current Accounts Payable $3.4M
Deferred Revenue -
Current Debt -
Short Term Debt $406K
Total Non Current Liabilities $436K
Capital Lease Obligations $805K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $805K
Other Current Liabilities $10M
Other Non Current Liabilities $37K
Total Shareholder Equity $61M
Treasury Stock -
Retained Earnings -$332M
Common Stock $7.1M
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (EUR)
Operating Cashflow -$49M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $485K
Capital Expenditures $47K
Change In Receivables -
Change In Inventory $4.5M
Profit Loss -
Cashflow From Investment $52M
Cashflow From Financing $386K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$46M

yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit -$3.2M
Total Revenue $166K
Cost Of Revenue $3.3M
Costof Goods And Services Sold $3.3M
Operating Income -$53M
Selling General And Administrative $15M
Research And Development $35M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $3.3M
Interest Income $3.2M
Interest Expense $21K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $485K
Income Before Tax -$46M
Income Tax Expense $5.2K
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$46M
Net Income -$46M

IFRX News

IFRX Profile

InflaRx N.V. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

InflaRx N.V. is a innovative clinical-stage biopharmaceutical company headquartered in Jena, Germany, with strategic operations in the United States, specializing in the development of novel C5a inhibitors that target the complement system to treat serious inflammatory and autoimmune diseases. The company’s lead asset, IFX-1, is currently being evaluated for indications such as hidradenitis suppurativa, showcasing InflaRx's commitment to addressing unmet medical needs through cutting-edge research and development. With a robust therapeutic pipeline and a focus on pioneering science, InflaRx is poised to make significant contributions to the biopharmaceutical landscape.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
ADTX
+21.01%
$3.80
DEFT
+9.35%
$1.52
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CAN
+0.75%
$0.92
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
NWTN
-9.09%
$0.70
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
APLD
+8.66%
$27.10
AG
+12.65%
$15.22
GOOG
-0.05%
$320.12
NGD
+6.50%
$8.35
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.76%
$17.28
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
NVO
+1.31%
$49.35
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
ADTX
+21.01%
$3.80
DEFT
+9.35%
$1.52
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CAN
+0.75%
$0.92
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
NWTN
-9.09%
$0.70
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
APLD
+8.66%
$27.10
AG
+12.65%
$15.22
GOOG
-0.05%
$320.12
NGD
+6.50%
$8.35
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.76%
$17.28
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
AGNC
+0.47%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
NVO
+1.31%
$49.35
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.